Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)

Medtronic Cardiac Rhythm and Heart Failure0 sites1,326 target enrollmentFebruary 2004

ConditionsVentricular Tachycardia Ventricular Fibrillation

Overview

Phase: N/A
Intervention: Not specified
Conditions: Ventricular Tachycardia
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Enrollment: 1326
Status: Completed
Last Updated: 18 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Registry

clinicaltrials.gov

Start Date

February 2004

End Date

January 2006

Last Updated

18 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

Eligibility Criteria

Inclusion Criteria

•Patients 18 years of age or older.
•Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
•New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.